Adding Lilly’s new drug to Zepbound helped people lose up to 23% of their weight. But there were more side effects.
发生了什么
The company is working on an experimental amylin drug to see if it can help people lose weight and manage their diabetes — much like a GLP-1.
摘要按规则整理自下方来源原文